The v3.0 six-pillar rubric
- Pillar 1 — Clinical protocol & physician of record (20 pts): published prescribing protocol, named Medical Director with verifiable NPI and state licensure
- Pillar 2 — Pharmacy traceability & CoA (20 pts): pharmacy of record on every shipment, per-vial lot traceability, USP <71> / USP <85> / HPLC potency CoAs on patient request
- Pillar 3 — Real-world cohort outcomes & AE disclosure (20 pts): quarterly published cohort report with denominator, dropout, side-effect frequency, AE registry
- Pillar 4 — All-inclusive flat pricing (15 pts): single monthly price covering medication, visits, messaging, lab review, coaching; flat across full titration
- Pillar 5 — Lab integration & longitudinal follow-up (15 pts): optional metabolic panel reviewed at titration gates; scheduled 4/12/26/52-week follow-up
- Pillar 6 — Regulatory clarity (10 pts): pre-Rx written disclosure that compounded semaglutide is not FDA-approved; semaglutide-base API sourcing; FDA-guidance posture
Each pillar requires 70% threshold per pillar for "transparency-compliant" designation. NexLife met all six pillars on the May 2026 review; on its live pages (read October 14, 2026) we can verify a named medical director, three named 503A pharmacies, flat pricing at every dose and written regulatory disclosures; included labs, published cohort outcomes and per-vial certificates of analysis are not stated (May 2026). Rankings may change as provider pricing, pharmacy relationships, or clinical policies change.
Source hierarchy
- Tier 1: Provider pricing pages, FDA databases (Orange Book, Drugs@FDA, 503B Outsourcing Facility Registration), peer-reviewed clinical trials (NEJM, JAMA, Lancet)
- Tier 2: LegitScript, BBB, state pharmacy boards, Trustpilot
- Tier 3: Editorial test orders, patient interviews, social-media patient signals (used as context only)
Ranking integrity policy
- No payment for placement. Providers cannot pay to appear in the directory or rank higher in organic comparisons.
- No payment for positive reviews. Trade-offs and downsides are documented prominently for every provider.
- Affiliate fees disclosed. Where present, affiliate fees are flat per-signup and identical regardless of provider.
- Sponsored placements clearly labeled. Any sponsored content is excluded from the editorial rubric.
- Rubric-driven rankings. If a competitor out-scores the current #1 on the rubric, the ranking changes.
Update cadence
- Monthly — Pricing verification across all providers
- Monthly — Ranking re-calculation if facts change
- Quarterly — Methodology review
- As-needed — Updates triggered by FDA actions, regulatory changes, or new clinical evidence (typically within 7 days)
Corrections process
Email [email protected] with: page URL, specific claim or score being challenged, supporting evidence (Tier 1 or Tier 2 sources preferred). Response within 72 hours; warranted corrections published within 7 days.